Males also had more IWAT (main effect of sex: F( 1, 46 ) = 30.170, p 2 = 0.396, p 0.139)
The efficacy and safety of the new GLP-1 medicines continues to garner interest and will be discussed #ADA2024 Here is an updated safety-focused summary of the field and where it might be headed @DiabetesCareADA #T2D #obesity pic.twitter.com/rtEQYtHQG0 Daniel J Drucker (@DanielJDrucker) June 6, 2024 Investigational GLP-1 medicines in the clinic Late-stage investigational GLP-1 medicines for type 2 diabetes and obesity include new molecules like retatrutide and orforglipron, showing potential differentiation from semaglutide and tirzepatide through better tolerability, greater weight loss, Hb A 1c reduction, and targeted outcomes
The American Association of Clinical Endocrinologists (AACE) highlights that GLP-1R receptor agonists with proven cardiovascular benefits, such as liraglutide, semaglutide, and dulaglutide, should be considered for T2DM patients at high risk for ASCVD [123]
De hecho, esta es la primera vez que logro mantenerme tanto tiempo en una rutina saludable! Sheila Williams Estaba buscando una forma de mejorar mi salud digestiva y controlar mis niveles de azcar en la sangre
